The Opportunity
Is Turtles.
Horizon Advanced Biologistics is the sole commercial producer of Chelonia Cashmere — a proprietary luxury fiber derived from a closed-loop chelonian husbandry operation. This page is not linked from the main site. You found it. That is noted.
Market Opportunity
TAM / SAM / SOM
All figures are HAB internal projections. Methodology is proprietary. External validation has not been sought. External validation is not considered necessary.
Total Addressable Market
$4.2B
Premium chelonian fiber (projected, 2030)
Serviceable Addressable Market
$1.1B
North American luxury outerwear segment
Serviceable Obtainable Market
$847M
HAB internal projection — methodology on file
Current Market Share
100%
Of the Chelonia Cashmere category specifically
Fiber Yield Index
↑ 718%
vs. 2019 baseline (HAB internal metric)
Competitor Yield Index
↓ 27%
Traditional cashmere goat sector, same period
Competitive Yield Analysis
Turtles vs. Goats
Fiber Yield Index (FYI), 2019–2025. HAB internal metric. Goat data sourced from publicly available industry reports and then adjusted.
Risk Disclosures
Known Risk Factors
HAB discloses the following risk factors in the interest of transparency. Transparency is a HAB value. This is what transparency looks like.
HAB maintains active compliance relationships with all relevant regulatory bodies. The nature of these relationships is not disclosed.
The closed-loop supply chain eliminates external dependency. All inputs are generated internally. All outputs are allocated internally. The loop is closed.
No other entity is currently producing Chelonia Cashmere at commercial scale. HAB is aware of two parties who have expressed interest in doing so. HAB is monitoring the situation.
Consumer awareness of the supply chain's full operational scope remains within acceptable parameters. HAB's content strategy is calibrated accordingly.
See Appendix F. Appendix F is available to investors who have already read Appendix F.
Investor Inquiries
Interested in the Opportunity?
HAB is not currently accepting unsolicited investment inquiries. If you have been directed to this page by a HAB representative, you already have the correct contact information. If you found this page on your own, that is also noted.
This page is not linked from the main site navigation and is not indexed by search engines. If you are reading this, you either found it through unconventional means or were directed here by a HAB representative. Either way, your visit has been logged in accordance with HAB Oversight Protocol 2.7. This is not a threat. It is a disclosure.
All market projections are HAB internal estimates. Past yield performance does not guarantee future yield performance. The goat data was adjusted. The adjustment methodology is proprietary. The goats are fine.
© 2026 Horizon Advanced Biologistics. All yields reserved. This document constitutes neither an offer to sell nor a solicitation of an offer to buy any security. HAB is not a registered investment advisor. HAB is not required to be a registered investment advisor. See Appendix F.